Verity Panel Discussion: 340B Outlook from Washington, D.C. & the States

SPONSORED CONTENT

Join us for coffee and listen to a panel of 340B national leaders for a discussion that promises to bring you unique and candid viewpoints on the latest 340B developments.

Read More »

Scoping 340B Referral Capture Opportunity: It’s Bigger Than You Think

SPONSORED CONTENT

Imagine the services you could offer to the community your facility serves if you had additional funding. If you’re a 340B covered entity (CE), referral capture might just pave the way to securing those much-needed funds.

The 340B program provides essential funding

Read More »

TPA Fees: Before You Sign on the Dotted Line

SPONSORED CONTENT

As the 340B program continues to grow in complexity, given the drug manufacturer restrictions, it is more important than ever for covered entities to have a firm grasp and understanding of the fees charged by their Third Party Adminisrators (TPAs) for their contract pharmacies. Whether it is

Read More »

Are You Prepared for an Office of Pharmacy Affairs (OPA) Audit?

SPONSORED CONTENT

All entities who participate in the 340B program are subject to an Office of Pharmacy Affairs (OPA) audit regardless of entity type, size or volume of transactions.  For the last five years, HRSA’s OPA has been completing approximately 200 audits a year and

Read More »

Consolidated Service Centers and 340B: Can they Coexist?

SPONSORED CONTENT

Consolidated Service Centers (CSCs) centralize many pharmacy services along with the inventory of a health system and capture significant savings through processes such as strategic buys, standardization, and low units of measure distribution, just to name a few. But the most frequently asked question by

Read More »

SUSTAIN 340B -The Imperative for a Clearinghouse to Strengthen the 340B Program

SPONSORED CONTENT

The 340B program remains essential in ensuring equitable access to crucial medications for vulnerable, underserved populations. The program provides safety net providers with critical resources necessary to expand health related services to low-income and uninsured individuals. Over the past decade, controversy,

Read More »

Guidance on 340B ESP Use and Management

SPONSORED CONTENT

Since 2020, select drug manufacturers have begun deploying restrictions or limitations on the sale of their products through the 340B program. This has proven to be a marketplace disruptor that has shifted the landscape of the 340B contract pharmacy program, as covered

Read More »

PBM is not a 4-letter word: How an independent PBM and an integrated pharmacy strategy provides value for your organization

SPONSORED CONTENT

Every dollar counts when you’re serving an underserved population. However, many organizations fail to incorporate a holistic approach to pharmacy and typically will separate pharmacy benefit management from pharmacy operations management. Creating an integrated pharmacy strategy can

Read More »

Three Things Hospitals and Grantees Need to Know About HRSA’s 340B Administrative Dispute Resolution Rule

SPONSORED CONTENT

On April 19, 2024—fourteen years after the Congressional deadline—the Health Resources and Services Administration published its final rule for the 340B Administrative Dispute Resolution process. Although HRSA restarted its stalled ADR rulemaking in 2020 after two 340B grantee organizations sued,

Read More »

Spring Cleaning of Your 340B Program

SPONSORED CONTENT

As we welcome the fresh energy of spring, now is the perfect time for 340B covered entities to conduct a thorough review and update of their 340B program. Ensuring your program’s compliance and efficiency is akin to spring cleaning—tidying up, organizing, and preparing for the year ahead. Below,

Read More »